Whether you are developing a drug eluting Stent, Balloon, Catheter, Patch, Biologic Matrix or other drug eluting or drug coated combination medical device, we can help. BASi®'s analytical groups have extensive experience determining drug levels associated with combination medical devices.
Maintaining a superior quality record has always been foremost for BASi®, and auditors are quick to compliment the processes we have implemented. We are responsive to client's specific needs; flexibility is key. We take extra effort to respond quickly to all inquiries and to complete studies on time, every time. BASi®'s leadership and partnership with clients around the world has helped successfully bring numerous combination products to market.
| Drugs | --------- Matrices --------- | Species | |
| Dexamethasone | Adipose | Lung | Dog |
| Donepezil | Arterial Wall | Muscle | Human |
| Everolimus | Coronary Artery & Vein | Myocardium | Mouse |
| Minocycline | CSF | Plasma | Pig |
| Paclitaxel | Dura | Serum | Rabbit |
| Rapamycin (Sirolimus) | Endocardium | Skin | Rat |
| Rifampin | Kidney | Spleen | |
| Tacrolimus | Liver | Whole Blood | |
* Validated assays not currently available for all drug/matrix/species combinations. Others can be validated upon request. Ask your BASi® representative or contact BASi for details. View the publicly available BASi® Assay List.
As big as the USP, and then some!